• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    Novogen Limited (NVGN)

    -NasdaqCM
    3.62 Up 0.08(2.26%) Jul 28, 3:59PM EDT
    Add to Portfolio
    Prev Close:3.54
    Open:3.51
    Bid:3.53 x 500
    Ask:5.25 x 500
    1y Target Est:6.27
    Beta:-2.76
    Next Earnings Date:N/A
    Day's Range:3.45 - 3.64
    52wk Range:1.51 - 9.50
    Volume:84,769
    Avg Vol (3m):337,440
    Market Cap:36.20M
    P/E (ttm):N/A
    EPS (ttm):-0.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.02
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback